A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

NCT00002236 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Delavirdine mesylate
DRUG: Zidovudine

Sponsor

Pharmacia and Upjohn